p.132 抽出テキスト

II160. PMID: 12970225 1055. Mair R, Tulzer G, Sames E, et al. Right ventricular to pulmonary artery conduit instead of modified Blalock-Taussig shunt improves postoperative hemodynamics in newborns after the Norwood operation. J Thorac Cardiovasc Surg 2003; 126: 1378-1384. PMID: 14666009 1056. Feinstein JA, Benson DW, Dubin AM, et al. Hypoplastic left heart syndrome: Current considerations and expectations. J Am Coll Cardiol 2012; 59: S1-42. PMID: 22192720 1057. Saraf A, Book WM, Nelson TJ, et al. Hypoplastic left heart syndrome: From bedside to bench and back. J Mol Cell Cardiol 2019; 135: 109-118. PMID: 31419439 1058. Mahle WT, Clancy RR, Moss EM, et al. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics 2000; 105: 1082-1089. PMID: 10790466 1059. Goldberg CS, Schwartz EM, Brunberg JA, et al. Neurodevelopmental outcome of patients after the fontan operation: A comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr 2000; 137: 646-652. PMID: 11060530 1060. Perloff JK, Rosove MH, Child JS, et al. Adults with cyanotic congenital heart disease: Hematologic management. Ann Intern Med 1988; 109: 406-413. PMID: 3044212 1061. Perloff JK. Cyanotic congenital heart disease: A multisystem disorder. In: Perloff JK, et al. editors. Congenital heart disease in adults, 3rd edn. WB Saunders/Elsevier, 2009: 1265-1289. 1062. Territo MC, Rosove MH. Cyanotic congenital heart disease: Hematologic management. J Am Coll Cardiol 1991; 18: 320-322. PMID: 1856391 1063. Rose SS, Shah AA, Hoover DR, et al. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis. J Gen Intern Med 2007; 22: 1775-1777. PMID: 17917783 1064. Blanche C, Alonso-Gonzalez R, Uribarri A, et al. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension. Int J Cardiol 2018; 267: 79-83. PMID: 29807779 1065. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 2004; 97 Suppl: 109-115. PMID: 15590087 1066. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 2002; 16: 752-765. PMID: 12486661 1067. Horigome H, Hiramatsu Y, Shigeta O, et al. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol 2002; 39: 1072-1077. PMID: 11897453 1068. Horigome H, Murakami T, Isobe T, et al. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. Thromb Res 2003; 112: 223-227. PMID: 14987915 1069. Silversides CK, Granton JT, Konen E, et al. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003; 42: 1982-1987. PMID: 14662263 1070. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996; 28: 768-772. PMID: 8772770 1071. Smith JMC, Andrade JG, Human D, et al. Adults With Complex Congenital Heart Disease: Cerebrovascular Considerations for the Neurologist. Front Neurol 2019; 10: 329. PMID: 31019488 1072. Burlet A, Drukker A, Guignard JP. Renal function in cyanotic congenital heart disease. Nephron 1999; 81: 296-300. PMID: 10050084 1073. Morgan C, Al-Aklabi M, Garcia Guerra G. Chronic kidney disease in congenital heart disease patients: A narrative review of evidence. Can J Kidney Health Dis 2015; 2: 27. PMID: 26266042 1074. Martínez-Quintana E, Rodríguez-González F, Fábregas-Brouard M, et al. Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients. Congenit Heart Dis 2009; 4: 147-152. PMID: 19489941 1075. Inatomi J, Matsuoka K, Fujimaru R, et al. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 2006; 21: 1440-1445. PMID: 16902784 1076. Rajpal S, Alshawabkeh L, Almaddah N, et al. Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank. JAMA Cardiol 2018; 3: 308-316. PMID: 29541749 1077. Oka H, Nakau K, Kajihama A, et al. Assessment of Potential Renal Dysfunction in Patients with Congenital Heart Disease after Biventricular Repair. Korean Circ J 2018; 48: 418-426. PMID: 29671286 1078. Hongsawong N, Khamdee P, Silvilairat S, et al. Prevalence and as-

sociated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease. Pediatr Nephrol 2018; 33: 493-501. PMID: 28971258 1079. Niwa K, Perloff JK, Kaplan S, et al. Eisenmenger syndrome in

adults: Ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 1999; 34: 223-232. PMID: 10400015 1080. Ohuchi H, Negishi J, Hayama Y, et al. Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation. Int J Cardiol 2015; 184: 623- 630. PMID: 25771227 1081. Chugh R, Perloff JK, Fishbein M, et al. Extramural coronary arteries in adults with cyanotic congenital heart disease. Am J Cardiol 2004; 94: 1355-1357. PMID: 15541268 1082. Pesonen E, Liuba P, Aburawi EH. Review findings included diminished coronary flow reserve after surgery in children with congenital heart disease and inflammation. Acta Paediatr 2019; 108: 218-223. PMID: 30312493 1083. Jenkins EL, Caputo M, Angelini GD, et al. Chronic hypoxia down-regulates tight junction protein ZO-2 expression in children with cyanotic congenital heart defect. ESC Heart Fail 2016; 3: 131- 137. PMID: 27398226 1084. Zhu L, Wang Q, Zhang L, et al. Hypoxia induces PGC-1α expression and mitochondrial biogenesis in the myocardium of TOF patients. Cell Res 2010; 20: 676-687. PMID: 20368732 1085. Broberg CS, Chugh SS, Conklin C, et al. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 2010; 3: 727- 734. PMID: 20855860 1086. Dickinson CJ. The aetiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest 1993; 23: 330-338. PMID: 8344332 1087. Wijesekera VA, Radford DJ. Hypertrophic osteoarthropathy in Eisenmenger syndrome. Congenit Heart Dis 2013; 8: E65-E69. PMID: 22309158 1088. Nguyen S, Hojjati M. Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy. Clin Rheumatol 2011; 30: 7-13. PMID: 20936419 1089. Vimala S, Krishnakumar M, Goyal A, et al. Perioperative Complications and Clinical Outcomes in Patients with Congenital Cyanotic Heart Disease Undergoing Surgery for Brain Abscess. J Neurosci Rural Pract 2020; 11: 375-380. PMID: 32753800 1090. Lumbiganon P, Chaikitpinyo A. Antibiotics for brain abscesses in people with cyanotic congenital heart disease. Cochrane Database Syst Rev 2013: CD004469. PMID: 23543532 1091. Kouchoukos NT, Blackstone EH, Doty DB, et al. Congenital aortic stenosis. In: Kirklin/Barratt-Boyes Cardiac Surgery, 3rd edn. Churchill Livingstone, 2003: 1265-1269. 1092. Khan SS, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001; 122: 257-269. PMID: 11479498 1093. Schnittman SR, Adams DH, Itagaki S, et al. Bioprosthetic aortic valve replacement: Revisiting prosthesis choice in patients younger than 50 years old. J Thorac Cardiovasc Surg 2018; 155: 539-547. e9. PMID: 29110948 1094. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329: 524-529. PMID: 8336751 1095. Keuleers S, Herijgers P, Herregods MC, et al. Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis. Am J Cardiol 2011; 107: 275-279. PMID: 21211605 1096. Huang G, Schaff HV, Sundt TM, et al. Treatment of obstructive thrombosed prosthetic heart valve. J Am Coll Cardiol 2013; 62: 1731-1736. PMID: 23994405 1097. Özkan M, Gündüz S, Gürsoy OM, et al. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Am Heart J 2015; 170: 409-418. PMID: 26299240 1098. 西畠信.僧帽弁狭窄.高尾篤良,門間和夫,中澤誠 編.臨床発達心臓病学 改訂3版.中外医学社 2001:445-448. 1099. McElhinney DB, Sherwood MC, Keane JF, et al. Current management of severe congenital mitral stenosis: Outcomes of transcatheter and surgical therapy in 108 infants and children. Circulation 2005; 112: 707-714. PMID: 16043648 1100. Hoashi T, Bove EL, Devaney EJ, et al. Mitral valve repair for congenital mitral valve stenosis in the pediatric population. Ann Thorac Surg 2010; 90: 36-41. PMID: 20609744 1101. Wood AE, Healy DG, Nolke L, et al. Mitral valve reconstruction in

a pediatric population: Late clinical results and predictors of longterm outcome. J Thorac Cardiovasc Surg 2005; 130: 66-73. PMID: 15999043